Predicting Corticosteroid-Free Biologic Remission with Vedolizumab in Crohn's Disease.
Sign Up to like & getrecommendations! Published in 2018 at "Inflammatory bowel diseases"
DOI: 10.1093/ibd/izy031
Abstract: Background and Aims Vedolizumab (VDZ) is effective for Crohn's disease (CD) but costly and is slow to produce remission. Early knowledge of whether vedolizumab is likely to succeed is valuable for physicians, patients, and insurers.… read more here.
Keywords: week; biologic remission; corticosteroid free; remission ... See more keywords